Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,735 | 500 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,382 | 182 | $0 (2024) |
| Janssen Biotech, Inc. | $1,267 | 69 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $573.90 | 29 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $451.61 | 39 | $0 (2024) |
| Celgene Corporation | $335.01 | 30 | $0 (2024) |
| Merck Sharp & Dohme LLC | $329.66 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $311.19 | 17 | $0 (2024) |
| QOL Medical, LLC | $227.43 | 13 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $221.68 | 16 | $0 (2021) |
| PFIZER INC. | $218.09 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,511 | 77 | ABBVIE INC. ($409.33) |
| 2023 | $689.40 | 52 | ABBVIE INC. ($264.34) |
| 2022 | $1,099 | 78 | ABBVIE INC. ($317.66) |
| 2021 | $1,055 | 72 | Janssen Biotech, Inc. ($289.02) |
| 2020 | $310.05 | 19 | AbbVie Inc. ($128.71) |
| 2019 | $1,260 | 87 | AbbVie, Inc. ($408.04) |
| 2018 | $1,092 | 67 | AbbVie, Inc. ($371.42) |
| 2017 | $719.21 | 48 | AbbVie, Inc. ($236.19) |
All Payment Transactions
500 individual payment records from CMS Open Payments — Page 20 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/21/2017 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE, SIMPONI | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology | ||||||
| 07/20/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.17 | General |
| 07/11/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $11.43 | General |
| Category: Immunology | ||||||
| 07/07/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/06/2017 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Anemia | ||||||
| 06/30/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Immunology | ||||||
| 06/14/2017 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE, SIMPONI | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Immunology | ||||||
| 05/26/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Immunology | ||||||
| 05/24/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/24/2017 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE, SIMPONI | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Immunology | ||||||
| 05/15/2017 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DELZICOL | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Gastroenterology | ||||||
| 05/01/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Endocrinology | ||||||
| 04/20/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/19/2017 | Ferring Pharmaceuticals Inc. | PREPOPIK (Drug) | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/10/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/03/2017 | Braintree Laboratories, Inc. | SUPREP (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/29/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Immunology | ||||||
| 03/09/2017 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Endocrinology | ||||||
| 02/27/2017 | Valeant Pharmaceuticals North America LLC | XIFAXANIBSD (Drug), UCERIS TABLETS, RELISTOR ORAL | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/17/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/10/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: INFLAMMATION | ||||||
| 02/10/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Immunology | ||||||
| 01/31/2017 | Merck Sharp & Dohme Corporation | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/13/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Immunology | ||||||
| 01/09/2017 | Shire North American Group Inc | LIALDA (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 702 | 735 | $780,154 | $208,847 |
| 2022 | 13 | 547 | 571 | $572,850 | $159,371 |
| 2021 | 15 | 695 | 729 | $752,030 | $226,779 |
| 2020 | 14 | 650 | 687 | $713,614 | $214,611 |
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 152 | 154 | $192,500 | $56,207 | 29.2% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2023 | 54 | 67 | $154,100 | $53,879 | 35.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 88 | 89 | $102,350 | $30,234 | 29.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 94 | 97 | $106,700 | $15,583 | 14.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 32 | 33 | $37,950 | $11,112 | 29.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 38 | 38 | $43,700 | $8,765 | 20.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 35 | 36 | $17,424 | $7,153 | 41.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 23 | 23 | $26,450 | $5,968 | 22.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Office | 2023 | 12 | 13 | $18,200 | $3,422 | 18.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 38 | 38 | $6,650 | $3,386 | 50.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Office | 2023 | 25 | 26 | $28,600 | $3,100 | 10.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 31 | 31 | $15,593 | $2,249 | 14.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 23 | $5,474 | $2,119 | 38.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 16 | $7,088 | $1,844 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,020 | $1,390 | 34.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $10,030 | $1,274 | 12.7% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 14 | 19 | $3,325 | $1,161 | 34.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 118 | 120 | $150,000 | $43,625 | 29.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Office | 2022 | 32 | 41 | $94,300 | $38,386 | 40.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 66 | 66 | $75,900 | $23,297 | 30.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 67 | 74 | $81,400 | $12,725 | 15.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 27 | 27 | $31,050 | $7,786 | 25.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 28 | $13,552 | $5,503 | 40.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 14 | 14 | $16,100 | $4,975 | 30.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 17 | 17 | $19,550 | $4,229 | 21.6% |
About Wei Hou, M.D., PH.D
Wei Hou, M.D., PH.D is a Gastroenterology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1811104037.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wei Hou, M.D., PH.D has received a total of $7,735 in payments from pharmaceutical and medical device companies, with $1,511 received in 2024. These payments were reported across 500 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,735).
As a Medicare-enrolled provider, Hou has provided services to 2,594 Medicare beneficiaries, totaling 2,722 services with total Medicare billing of $809,608. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lynchburg, VA
- Active Since 05/17/2007
- Last Updated 07/22/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1811104037
Products in Payments
- STELARA (Biological) $984.52
- Humira (Biological) $680.15
- Linzess (Drug) $465.15
- RINVOQ (Biological) $443.05
- ZEPOSIA (Drug) $335.01
- DIFICID (Drug) $318.49
- HUMIRA (Biological) $300.07
- LINZESS (Drug) $273.60
- TREMFYA (Drug) $267.93
- CREON (Drug) $237.67
- XIFAXAN (Drug) $233.83
- SUCRAID (Drug) $227.43
- ENTYVIO (Biological) $214.55
- Cimzia (Drug) $194.54
- Entyvio (Biological) $164.26
- XELJANZ (Drug) $163.94
- VOQUEZNA (Drug) $158.37
- SKYRIZI (Biological) $137.81
- VIBERZI (Drug) $118.97
- CLENPIQ (Drug) $108.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lynchburg
Larry Clark, M.d, M.D
Gastroenterology — Payments: $1.3M
Ralph Wisniewski, M.d, M.D
Gastroenterology — Payments: $6,349
Robert Richards, M.d, M.D
Gastroenterology — Payments: $4,516
Loretta Maffei, M.d, M.D
Gastroenterology — Payments: $2,537
James Curtiss, Md, MD
Gastroenterology — Payments: $350.87
Charles Catalano, M.d, M.D
Gastroenterology — Payments: $70.52